Results 161 to 170 of about 8,451 (198)

Pediatric spontaneous-reporting patterns for biologics approved or used for asthma: Analysis of the FDA adverse event reporting system. [PDF]

Pediatr Allergy Immunol
Zhang Y, Liu Y, Chen L, Chen Y, Zheng X.
europepmc   +1 more source

Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma on Anti-Inteleurkin-5 Biologics. [PDF]

Chest
Rivard R, Mailhot-Larouche S, Borg C, Pujan P, Klein M, Lachapelle P, Couillard S.   +6 more
europepmc   +1 more source

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin. [PDF]

Eur Respir J
Whetstone C, Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L, Howie K, Killian K, Holt K, Sehmi R, Smith JA, O'Byrne PM, Satia I, Gauvreau GM.   +17 more
europepmc   +1 more source

Depemokimab: A twice yearly anti-IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) - A narrative review. [PDF]

Hum Vaccin Immunother
Park MJ, Han JK, Lam KK.
europepmc   +1 more source

Steroid-Free Remission of Eosinophilic Granulomatosis With Polyangiitis Achieved With Low-Dose Mepolizumab: A Case Report. [PDF]

Clin Case Rep
Matsuoka S, Takigawa Y, Nishimura J, Watanabe H, Kudo K, Sato K, Fujiwara K, Shibayama T.   +7 more
europepmc   +1 more source

COMSA-MEWS: a simple quantitative algorithm for determining response to biologics in severe asthma, tested in a real-world mepolizumab study. [PDF]

ERJ Open Res
Yasinska V, Kolmert J, Sparreman Mikus M, Andersson LI, Lantz AS, Wallen-Nielsén E, Bossios A, Lazarinis N, Tenselius O, Rydell N, Wheelock CE, Howarth PH, Brightling C, Malinovschi A, Janson C, Mjösberg J, Dahlén B, James A, Dahlén SE.   +18 more
europepmc   +1 more source

Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) with Mepolizumab or Dupilumab: A Preliminary Single-Center Study for Evaluation of Safety and Efficacy. [PDF]

J Pers Med
Bertolini M, Fucci L, Guastini L, Conti C, Santori G, Canevari FRM.   +5 more
europepmc   +1 more source

Biologics in Older Adults with Chronic Obstructive Pulmonary Disease: A Narrative Review. [PDF]

J Clin Med
Scarlata S, Marinelli A, Finamore P, Quaranta VN, Amoroso G, Tomasello A, Sorino C, Carpagnano GE, Scichilone N, Dragonieri S.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mepolizumab

Reactions Weekly, 2022
  +10 more sources